T

Travere Therapeutics

Biotechnology · United States · 1,000 employees

156 Decision makers
+21 New (6 months)
1,000 Employees
$591M Revenue
2020 Founded

Organizational Chart of Travere Therapeutics

Roles identified within Travere Therapeutics's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Travere Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Travere Therapeutics by function

General management

Finance

Other functions

See all Travere Therapeutics contacts on Zeliq

Decision makers at Travere Therapeutics

156 identified 3 C-Level 18 VP 135 Directors +21 new (6 months)
See them on Zeliq →

Departments actively hiring 11 departments

Consulting
Engineering and technical
Finance & accounting
General management
Human resources
Marketing
Medical
Operations
Other
Project management
Research

These departments at Travere Therapeutics are actively recruiting: a strong signal to time your outreach.

Funding and news at Travere Therapeutics

Funding

Last round Other · $475M
Total funding $1.5B (11 rounds)
Series A $4M May 2012
Post-IPO Equity $25M Aug 2013
Post-IPO Equity $46M May 2014
Post-IPO Debt $45M Jul 2014
Post-IPO Equity $150M Mar 2015
Post-IPO Equity $202M Feb 2021
Post-IPO Debt $275M Mar 2022
Post-IPO Equity $200M Feb 2023
Post-IPO Equity $125M Nov 2024
Post-IPO Equity N/A Jan 2026
Post-IPO Debt $475M May 2026

Latest news at Travere Therapeutics

  1. Appointment

    New Director, Access and Reimbursement appointed — Medical

  2. Appointment

    New Director Translational Immunology appointed — Research

  3. Appointment

    New Associate Director, Statistical Programming appointed — Research

  4. Appointment

    New Associate Director appointed — General management

  5. Appointment

    New Associate Director, Bioanalytical Sciences appointed — Research

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Medical
82
Sales
75
Hiring Other
49
Hiring Finance
44
Hiring General Management
39
Hiring Operations
30
Hiring Research
24
Hiring HR
18

How to prospect Travere Therapeutics's departments

Medical

With 82 people, this is the organisation's biggest team, and it is hiring. Medical teams trust peer references: name comparable organisations you already serve.

Other

A team of 49 people, currently hiring. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

Finance

This 44-person department is actively recruiting. Build your pitch around ROI, payback period and risk reduction: the language this department speaks.

General Management

Hiring is underway in this team of 39 people. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Operations

A team of 30 people, currently hiring. Process efficiency and cost control are the angles that resonate with these decision makers.

Research

This 24-person department is actively recruiting. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Try the Zeliq email finder demo →

FAQ Travere Therapeutics

Who runs Travere Therapeutics?

The highest-ranking leadership role identified at Travere Therapeutics is “CFO”, based on public data updated 25 Oct 2026.

How many decision makers does Travere Therapeutics have?

156 decision makers identified, including 3 at executive level.

How do I contact a decision maker at Travere Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Travere Therapeutics?

Consulting, Engineering and technical and Finance & accounting, based on published job offers as of 25 Oct 2026.

Companies similar to Travere Therapeutics

More companies to explore

Biotechnology · United States

All Biotechnology companies in United States →

About Travere Therapeutics

Travere Therapeutics operates in the Biotechnology industry, operating from United States. Established in 2020, it has a workforce of roughly 1,000 people. Within the wider Hospitals and Health Care sector, Travere Therapeutics focuses on the Biotechnology segment. Travere Therapeutics sells primarily to other businesses (B2B) rather than to end consumers. The company has secured 11 rounds of funding totalling $1.5B. The company generates approximately $591M in annual revenue. This profile compiles key information about Travere Therapeutics, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Travere Therapeutics operates in the Biotechnology segment, part of the broader Hospitals and Health Care sector. As a B2B company, Travere Therapeutics primarily serves business clients and professional organisations. The company is categorised as “Public company”.